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Renal tubular calcium (RTCa) transport is one of the main factors that determine serum Ca concentration and urinary Ca
excretion. The distal convoluted and connecting tubules reabsorb a significant fraction (10%) of filtered Ca. These tubule
segments also synthesize in large abundance tissue kallikrein (TK), a major kinin-forming enzyme. Tested was the hypothesis
that TK and kinins are involved in controlling RTCa transport by studying TK (TK/) or kinin B2 receptor (B2/)-deficient
mice on different Ca diets. On a 0.9% wt/wt Ca diet, 129Sv or C57Bl/6 TK/mice excreted significantly more Ca in urine than
their wild-type (WT) littermates. There was no difference between TK/ and WT mice for plasma concentrations of Ca, Mg,
creatinine, parathyroid hormone, or 1,25-dihydroxyvitamin D. On a low Ca (LCa) diet (0.01% wt/wt), urinary Ca excretion
decreased in both TK/ and WT mice but still remained higher in TK/ mice compared with WT. The plasma Ca
concentration was unchanged in C57Bl/6 TK/mice but decreased significantly in 129Sv TK/mice. Taken together, these
data demonstrate that TK deficiency led to impaired RTCa absorption. On the LCa diet, renal TK gene expression doubled in
WT mice. No change in urinary Ca excretion was observed in B2/ mice, even after treatment with a kinin B1-receptor
antagonist, and these mice adapted normally to the LCa diet. TK deficiency had no effect on the renal abundance of distal Ca
transporter mRNA. These data suggest that TK may be a physiologic regulator of RTCa transport, acting through a
non–kinin-mediated mechanism.
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R enal tubular Ca (RTCa) reabsorption is a direct deter-minant of urinary Ca excretion and the concentrationof Ca in the extracellular fluid (ECF). Indeed, by
matching the amount of Ca that is excreted in urine to the
amount of Ca that enters the ECF compartment, the renal
tubule keeps the ECF Ca concentration virtually constant (1).
Accordingly, any impairment of the ability of the renal tubule
to reabsorb the appropriate amount of Ca can affect both uri-
nary Ca excretion and the ECF Ca concentration. As a conse-
quence, in patients with familial benign hypercalcemia and
primary hyperparathyroidism, plasma Ca concentration is re-
lated to tubular Ca reabsorption (2,3).
Under normal conditions, renal tubular Ca reabsorption is
tightly regulated. Nonhormonal factors, such as ECF volume,
acid/base status, and plasmaMg and Ca concentrations, influence
the handling of Ca in the renal tubule (4–6). Extrarenal hormonal
factors, such as parathyroid hormone (PTH) and 1,25-dihy-
droxyvitamin D, also regulate tubular Ca reabsorption (7). In
contrast, relatively little is known about the possible contribution
of intrarenal factors in regulating renal tubular Ca transport.
Recently, the molecular basis of the active transcellular trans-
port of Ca in the distal nephron has been unraveled. This process
involves the apical influx of Ca through the epithelial Ca channel
(TRPV5), which is the rate-limiting step in transcellular Ca trans-
port (8). Accordingly, the lack of TRPV5 leads to a decrease in
distal tubule Ca reclamation and hypercalciuria of renal origin (9).
It is noteworthy that one of the major proteins that are
synthesized in the distal tubule and secreted into the tubular
fluid is tissue kallikrein (TK) (10–12). TK is the main kinin-
forming enzyme in mammals (13), but its function in the renal
tubule remains largely unknown. Here we show that TK-defi-
cient mice display hypercalciuria of renal origin. The distribu-
tion of TK largely overlaps with that of TRPV5 in the distal
nephron, and kallikrein gene expression is increased by a
low-Ca diet. We therefore suggest that kallikrein may be a
physiologic regulator of Ca metabolism.
Materials and Methods
Animals and Diets
TK-deficient mice (TK/) were produced in our laboratory as
described previously (13). The consequence of kallikrein deficiency in
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mice was studied in two different genetic backgrounds. To do this, mice
that bear the kallikrein gene–inactivating mutation were backcrossed
for 10 generations with pure strains of 129Sv or C57Bl/6 mice (IFFA
Credo, L’Arbresle, France) (13,14). Kinin B2 receptor–deficient mice
(B2/) were also studied (15). These mice were obtained from the
Jackson Laboratory (Bar Harbor, ME) and backcrossed for 10 gener-
ations with C57Bl/6 mice (14).
For each experiment, the mutated (TK/ or B2/) mice and
their wild-type (WT) littermates were produced by heterozygous cross-
ing. The studies were performed in 3- to 6-mo-old female or male mice.
They were fed two different semisynthetic diets (UAR, Epinay sur
Orge, France). Both diets contained 0.3% wt/wt sodium (Na), 0.9%
wt/wt potassium (K), but differing Ca contents. The normal Ca (NCa)
diet contained 0.9% wt/wt Ca, and the low Ca (LCa) diet contained
0.01% wt/wt Ca. The mice had free access to food and distilled water.
All of the experimental procedures were performed in accordance with
the European Guidelines for the care and use of laboratory animals.
Experimental Protocols
Study of Urinary Ca Excretion under Basal (NCa diet) Conditions.
In three separate experiments, the female 129Sv TK/ mice (n  19)
and their female WT littermates (n  20), the female C57Bl/6 TK/
(n  23) mice and their female WT littermates (n  26), or the male
C57Bl/6 TK/ mice (n  15) and their male WT littermates (n  14)
were equilibrated for 14 d on the NCa diet. The mice then were housed
individually in metabolic cages (Marty Technology, Marcilly sur Eure,
France) for a 24-h period of urine collection; the mice were allowed to
adapt to these cages for 1 d before collection began. The animals then
were anesthetized by an intraperitoneal injection of ketamine (0.1 mg/g
body wt) and xylazine (0.01 mg/g body wt), and blood was collected
by orbital puncture in heparinized capillaries tubes. The urine and
plasma samples were frozen at 20°C until analyzed.
Effect of a LCa Diet. In other sets of experiments, designed to
study the ability of mice to adapt to a LCa diet, either female 129Sv
TK/ (n 11) andWT (n 11) mice or female C57Bl/6 TK/ (n
9) mice and WT (n  10) mice were equilibrated for 14 d on the NCa
diet and then switched to the LCa diet for an additional 14 d. At the end
of the LCa period, 24-h urine and blood were collected as described
above. At the end of the collection, the kidneys were removed and
immediately frozen in liquid nitrogen for subsequent molecular stud-
ies.
Effect of Kinin B2-Receptor Inactivation (B2/) and of Kinin
B1-Receptor Blockade in B2/ Mice. Female B2/ mice were
equilibrated for 7 d on the NCa diet and then treated for an additional
7 d, while maintained on the same diet, with either the specific, non-
peptidic, kinin B1-receptor antagonist SSR240612, 1 mg/kg intraperi-
toneally (n  12), daily (gift from Dr. J. Gougat, Sanofi-Synthelabo,
Montpellier, France) (16), or its vehicle, saline  2% vol/vol DMSO
(n  10). WT littermates (n  10) were equilibrated in the same way as
the B2/ mice on the NCa diet and then treated with the vehicle for
7 d. Urine and blood were collected as above. The SSR240612 was
provided by Dr. J. Gougat. In another experiment, B2/mice (n  6)
and their WT littermates (n  8) were studied while on the LCa diet, as
described above.
Measurement of Biologic Parameters in Plasma and Urine
Plasma Ca and Mg concentrations were measured by atomic absorp-
tion spectrophotometry (Perkin Elmer Apparatus, Model 3110, Cort-
abeuf, France). Plasma creatinine was measured by an automatic enzy-
matic method (Kodak Biolyzer, Eastman Kodak, Rochester, NY). The
plasma concentration of 1,25-dihydroxyvitamin D was measured by a
receptor competition assay (Dia Sorin, Stillwater, MN), and that of PTH
was measured by an ELISA (Mouse Intact PTH ELISA kit; Immutopics,
San Clemente, CA).
The urinary Na concentration (UNa) was measured by flame-spec-
trophotometry (Flame Photometer 943; Instrumentation Laboratory,
Paris, France), the urinary Ca (UCa) and magnesium (UMg) concentra-
tions were measured by atomic absorption spectrophotometry as
above, and the urinary creatinine (UCr) concentration was measured by
a modified, kinetic Jaffe´ colorimetric method (RAXT; Bayer, Le-
verkusen, Germany). Urinary free deoxypyridinoline (DPyr) and cAMP
were measured by RIA (Nichols Institute Diagnostics, San Juan Cap-
istrano, CA; and Amersham, Little Chalfont, UK, respectively). UNa,
UCa, UMg, DPyr, and cAMP excretions were expressed as a ratio to the
UCr excretion to take into account the variations in urine collection.
Plasma and urinary phosphate concentrations were measured by a
colorimetric method.
Measurement of Renal Kallikrein mRNA by Northern
Blotting
Total RNA was extracted from one kidney of each mouse by the
phenol/guanidium isothiocyanate method (Trireagent; Molecular Re-
search Center, Cincinatti, Ohio) and checked for quality on agarose gel
(17). Kallikrein mRNA was quantified by Northern blotting with a
mouse kallikrein cDNA probe, as described previously (13).
Measurement of TRPV5, TRPV6, NCX1, PMCA1b, and
Calbindins Gene Expression by Quantitative Real-Time PCR
Kidney RNA, prepared as described above, was DNase treated and
reverse transcribed using Moloney murine leukemia virus reverse tran-
scriptase (Life Technologies, Cergy Pontoise, France). Quantitative,
real-time PCR reactions were performed on an ABI-PRISM 7700 se-
quence detector (Gene-AmpPCR system 9600; PE Biosystems, Foster
City, CA). The primers and fluorescence probes for mouse TRPV5,
TRPV6, NCX1, PMCA1b, Calbindin-D9k, Calbindin-D28k, and hypox-
anthine-guanine phosphoribosyl transferase and the PCR conditions
have been described elsewhere (8,18). Standard curves were used to
calculate the copy number of the target genes in each sample, expressed
as a ratio to the hypoxanthine-guanine phosphoribosyl transferase
gene.
Immunohistochemical Studies
Fixation of mouse kidneys and the subsequent immunohistochemis-
try were performed as described previously (19). Serial cryosections
were taken and incubated at 4°C overnight with previously described
guinea pig/anti-rabbit TRPV5 diluted 1:400 (20), rabbit/anti-rat TK
diluted 1:10,000 (as described [13]). Binding sites of the primary anti-
bodies were detected using Cy3-conjugated goat/anti–guinea pig and
goat/anti-rabbit IgG (Jackson ImmunoResearch Laboratories, West
Grove, PA), respectively. To determine the nonspecific antibody bind-
ing, the primary antibodies were omitted or replaced by nonimmune
guinea pig and rabbit sera, respectively. Sections were studied by
epifluorescence with a Polyvar microscope (Reichert Jung, Vienna,
Austria), and digital images were acquired with a charged coupled
device camera.
Statistical Analyses
Values are expressed as mean  SEM. Comparisons were made by
using t test for unpaired values or the Mann-Whitney test, as appro-
priate, and ANOVA for multiple groups (Statview 5.0 statistical soft-
ware; SAS, Cary, NC). P  0.05 was considered to be statistically
significant.
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Results
Immunolocalization of Kallikrein and the Epithelial Ca
Channel (TRPV5) in the Distal Nephron
As described previously (19,21), TRPV5 and TK were detect-
able by immunohistochemistry in tubular profiles of the late
distal convoluted tubule (DCT) and the connecting tubule
(CNT) in the kidneys of WT mice. No TK was detectable in the
tubular profiles of the TK/ mice. As shown in Figure 1, the
distribution of TRPV5 and TK overlapped to a considerable
extent, although the two distribution patterns were not identi-
cal. TRPV5 immunostaining was bright in late DCT profiles and
more faint in CNT profiles. The subcellular localization of
TRPV5 shifted progressively from a predominantly apical lo-
calization in late DCT to a predominantly intracellular localiza-
tion in the late portions of the CNT. In contrast, TK immuno-
staining was faint in late DCT but strong in early CNT. The
immunofluorescent signal for TK diminished along the CNT
and the late, TRPV5-positive, CNT segments were consistently
not stained by the TK antibody (Figure 1).
Renal Ca Handling in TK-Deficient Mice
The data for the female TK/ mice and their WT litter-
mates are shown in Table 1 and Figure 2 for 129Sv mice and
Table 2 and Figure 2 for C57Bl/6 mice. Body weight, food
intake, urinary volume, creatinine, and Na excretions did not
differ between the WT and TK/ mice on either diet in both
strains. Differences between 129Sv and C57bl/6 mice were
observed for food intake and the excretion of urinary ions. The
plasma Ca concentration was the same in C57Bl/6 and 129Sv
mice, but urinary Ca excretion was lower in C57Bl/6 mice.
Taken together, these data suggest important interstrain differ-
ences in intestinal Ca absorption. On the NCa diet, UCa excre-
tion was significantly higher in the TK/ than the female WT
mice in both strains. In 129Sv mice, the difference was also
present when UCa was normalized to creatinine or Na excre-
tion to take into account possible interanimal differences in
urine sampling and/or food intake. In C57Bl/6 mice, when
normalized to UCr excretion, Ca excretion also tended to be
higher (P 0.069) in TK/mice than inWTmice. Plasma Ca,
creatinine, and protein concentrations did not differ between
TK/ and WT mice. Plasma 1,25-dihydroxyvitamin D and
PTH levels and cAMP and DPyr excretions were also the same
in both genotypes. Plasma phosphate concentration and uri-
nary phosphate excretion, measured in C57Bl/6 mice, did not
differ between genotypes.
On the LCa diet, UCa excretion was lower than on the NCa
diet (Table 1 and Figure 2). In both strains, the UCa/UCr ratio
remained higher in female TK/mice than in WT mice. This
difference persisted when UCa excretion was expressed as a
ratio to UNa excretion. Unlike the WT mice, which remained
normocalcemic, the female 129Sv TK/ mice exhibited sig-
nificant hypocalcemia. Plasma Ca concentration decreased by
approximately 0.35 mmol/L (P  0.05; Table 1 and Figure 2).
However, in C57Bl/6 mice, plasma Ca concentration remained
normal in TK/ mice. In both strains, plasma PTH concen-
tration tended to be higher on the LCa diet in both WT and
TK/ mice, although the effect remained below the thresh-
old of statistical significance. However, in both genotypes, uri-
nary cAMP excretion was higher on the LCa diet than on the
NCa diet (Tables 1 and 2). There was no difference between
genotypes for PTH levels or urinary cAMP excretions. Urinary
DPyr excretion was also higher on the LCa diet than on the
NCa diet in both WT and TK/ mice. Finally, in the WT
129Sv and C57Bl/6 mice, plasma 1,25-dihydroxyvitamin D con-
centration was higher on the LCa diet than on the NCa diet.
This increase was also observed in the C57Bl/6 TK/ mice
but not in 129Sv TK/ mice.
Male C57Bl/6 TK/ and WT mice were also studied, as
presented in Table 3. Compared with WT littermates, TK/
mice exhibited significant hypercalciuria. Plasma Ca, protein,
creatinine, PTH, and phosphate concentrations did not differ
between genotypes, whereas 1,25 dihydroxyvitamin D levels
were significantly higher in TK/ mice.
Effect of B2 Deficiency and B1 Antagonism on Renal
Ca Handling
The data for the C57Bl/6 B2-deficient mice and their WT
littermates that were studied on the NCa diet are shown in
Table 4. UCa excretion, plasma Ca, and 1,25-dihydroxy-vitamin
D concentrations were the same for both genotypes.
In a separate set of experiments, B2/ mice and their WT
littermates were studied on the LCa diet. After 14 d of Ca
restriction, UCa excretion was the same in B2/ and WT
mice (0.93  0.19 versus 1.06  0.27 mol/24 h, WT and
B2/, respectively). Similarly, no difference in plasma Ca
Figure 1. Distribution of TRPV5 and tissue kallikrein (TK) in the
kidney of a wild-type (WT) mouse. Consecutive cryosections
immunostained with an affinity-purified guinea pig anti-rabbit
TRPV5 antibody and a rabbit anti-rat TK antiserum, followed
by Cy3-conjugated goat/anti–guinea pig and goat/anti-rabbit
IgG, respectively. TRPV5 and TK immunostaining are co-local-
ized in late distal convoluted tubules (D) and early and middle
portions of connecting tubules (CN). While TK immunostain-
ing has vanished, TRPV5 is also detectable in the late portion of
the connecting tubule (CN*); weak immunostaining in cortical
radial veins (V) is due to unspecific binding of goat/anti–
guinea pig IgG to endothelial cells. Bar approximately 50 m.
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concentration was observed (2.05 0.11 versus 2.03 0.11 mM,
WT and B2/, respectively). These data indicate that the
B2/ mice were able to adapt normally to the LCa diet.
A subset of B2/mice were treated with the B1 antagonist
SSR240612 while on the NCa diet. B1-antagonist treatment of
the B2/ mice had no effect on their UCa excretion or other
parameters (Table 4).
Kallikrein Gene Expression in the Kidney
As shown in Figure 3, in 129Sv WT mice, renal TK mRNA
levels were twice as high on the LCa diet than on the NCa diet
(P  0.001). As expected, no kallikrein mRNA was detected in
TK/ mice.
Gene Expression of Ca Transporters in the Distal Nephron
To investigate the effect of the absence of TK on the expres-
sion of several renal distal Ca transporters genes, we performed
quantitative real-time PCR on TRPV5, TRPV6, NCX1, PMCA1b,
Calbindin-D9k, and Calbindin-D28k mRNA using total kidney
RNA from 129Sv TK/ and WT mice that were subjected to
either the NCa or the LCa diet (Table 5). In both genotypes,
Calbindin-D9k gene expression was significantly higher on the
LCa diet than on the NCa diet. No effect of the diet was
observed for TRPV5 gene expression. Calbindin-D28k mRNA
was downregulated on the LCa diet. None of these Ca trans-
porter mRNA levels differed in TK/ and WT mice. Similar
results were observed in C57Bl/6 WT and TK/ mice on the
NCa diet (data not shown).
Discussion
The intrarenal factors that are involved in the control of tubular
Ca reabsorption are largely unknown. Here we report data ob-
tained with genetically deficient mice, suggesting that renal kal-
likrein is involved in the control of tubular Ca reabsorption.
The genetic background of the mice can strongly influence the
phenotype linked to gene-inactivating mutations by means of
counterregulation processes (22). We observed this gene-interac-
tion effect in the kallikrein-deficient mice for cardiac morphology
and function (13,14). Our study documents differences in UCa
excretion between the C57Bl/6 and 129Sv mouse strains. Despite
their higher food intake, the C57Bl/6 mice had lower UCa excre-
tion, suggesting lower intestinal Ca absorption. Similarly, the
change in plasma Ca concentration that occurs in 129Sv TK/
mice on a LCa diet is not observed in C57Bl/6 TK/. However,
despite these interstrain differences in Cametabolism, the effect of
kallikrein gene inactivation on UCa excretion was reproducible in
both strains. This suggests that kallikrein may play an important
role in the renal Ca handling.
While on a 0.9% wt/wt Ca diet, both male and female
TK/ mice exhibited significant hypercalciuria. 129Sv and
C57Bl/6 TK/ mice excreted approximately 50% more UCa
Table 1. Phenotypic characterization of female 129Sv TK/ and WT littermates on NCa diet (0.9% wt/wt) or on
LCa diet (0.01% wt/wt Ca)a
0.9% Wt/Wt Ca 0.01% Wt/Wt Ca
WT (n  19) TK/ (n  20) WT (n  11) TK/ (n  11)
Weight (g) 24.7 0.9 23.9 1 21.7  0.6 21.6  0.6
Food intake (g/24 h) 1.92 0.36 1.89 0.35 1.25 0.35 1.07 0.33
Urine values
volume (ml/24 h) 1.10 0.14 1.25 0.14 0.90 0.11 1.10 0.11
creatinine excretion (mol/24 h) 4.48 0.33 4.91 0.32 3.87 0.22 4.00 0.21
Ca excretion (mol/24 h) 4.72 0.60 6.85 0.58b 1.00 0.18 1.49 0.17
UCa/UCr (mmol/mmol) 1.09 0.11 1.51 0.18b 0.25 0.04 0.38 0.04b
UNa/UCr (mmol/mmol) 36.2 2 30.8 1.9 37.5  3.3 31.4  3.2
UCa/UNa (mol/mmol) 33.2 7.6 56.6  7.5b 7.1 1.1 12.2 1.1b
UMg/UCr (mmol/mmol) 2.83 0.18 3.05 0.18 4.34 0.42 3.78 0.40
UDPyr/UCr (nmol/mmol) 9.86 0.68 9.99 2.03 15.49 0.63c 13.64 0.60c
UcAMP/UCr (mol/mmol) 6.16 0.32 5.62 1.02 8.89 0.66c 8.69 0.44c
Plasma values
total Ca (mM) 1.92 0.07 1.87 0.1 1.85  0.1 1.50  0.06b
magnesium (mM) 0.83 0.02 0.80 0.02 0.88 0.02 0.86 0.02
protein (g/L) 45.3 1.9 45.6  2.8 45.2  0.9 43.8  1.8
creatinine (M) 9.7 2.0 9.8 1.6 9.3  1.2 8.5  1.5
PTH (pg/ml) 6.8 2.2 12.5 4.2 26.7 16.3 29.9 14.8
1,25-dihydroxyvitamin D (pmol/L) 64 12 76  15 113  13 72  8b
aTK/, tissue kallikrein–deficient; WT, wild-type; UCa, urinary calcium; UCr, urinary creatinine; UNa, urinary sodium;
UMg, urinary magnesium; UcAMP, urinary cAMP; PTH, parathyroid hormone.
bP  0.05 versus WT on same diet.
cP  0.05 versus NCa diet.
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than did 129Sv and C57Bl/6WTmice, respectively, whereas for
both strains, UCa excretion was within the ranges previously
reported for WT mice (23,24). Hypercalciuria in TK/mice is
observed in the absence of any difference in plasma Ca or
creatinine concentration, suggesting that the Ca filtered loads
are similar in WT and TK/ mice.
At steady state, an increase in UCa excretion can be the
consequence of three distinct primary disorders: An increase in
intestinal Ca absorption, an increase in net bone resorption,
and, finally, a decrease in renal tubular Ca reabsorption. As
stated by Bushinsky et al. (25), each condition is responsible for
a recognizable phenotype. A convenient way to distinguish
between these disorders is to challenge the animals with a very
low Ca diet for several days. Hypercalciuria that depends on
increased intestinal Ca absorption can be expected to disappear
under these conditions. However, when the primary mecha-
nism is a decreased ability of the renal tubule to reabsorb the
appropriate amount of filtered Ca, the renal loss of Ca can be
expected to induce either persistent hypercalciuria, when the
loss of Ca can be compensated for by an increase in bone Ca
release, or a significant decrease in blood Ca concentration. For
example, genetically hypercalciuric rats, which have defective
tubular Ca reabsorption (26), display higher UCa excretion than
normal rats when fed an NCa diet. Moreover, on a LCa diet, the
blood Ca concentration in these animals decreases significantly
and UCa excretion decreases but remains higher than that in
normal rats that are fed the same diet (27). The difference in
UCa excretion observed under these conditions is assumed to
correspond to a higher bone Ca release in hypercalciuric rats.
Indeed, when hypercalciuric rats that are fed a LCa diet are
treated with alendronate, a potent bone resorption inhibitor,
their UCa excretion falls to the same level as in the normal
rats (25).
In our experiments, as expected, UCa excretion was lower in
both TK/ andWTmice on the LCa than on the NCa diet. At
the new steady state, however, UCa excretion remained higher
in TK/ than in WT mice; urinary DPyr excretion similarly
increased in TK/ and WT mice, indicating an appropriate
increase in bone resorption on the LCa diet, in both genotypes.
This increase in bone resorption and Ca release is sufficient to
maintain a normal plasma concentration of Ca in WT mice,
which have renal tubules with a normal ability to reabsorb Ca.
It is also sufficient to maintain a normal plasma Ca value in
C57Bl/6 TK/ mice but not in 129Sv TK/ mice. Some
striking interstrain differences in the response of calciotropic
hormones can be observed: Plasma PTH and 1,25 dihydroxyvi-
tamin D concentrations appropriately increase in C57Bl/6
TK/ mice but not in 129Sv TK/ mice. Indeed in 129Sv
TK/, the LCa diet induces a similar increase in PTH con-
centration as in WT mice despite the occurrence of hypocalce-
mia in TK/ mice. In addition, no change in 1,25 dihy-
droxyvitamin D is observed in 129Sv TK/ mice on a LCa
diet. Conversely, in C57Bl/6 mice, plasma PTH and 1,25 dihy-
droxyvitamin D concentrations both increase to the same extent
Figure 2.Urinary Ca excretion (129Sv mice [A]; C57Bl/6 mice [C]) and total plasma Ca concentration (129Sv mice [B]; C57Bl/6 mice
[D]) of WT (u) and TK/ () mice that were fed the normal Ca (NCa) diet (0.9% wt/wt Ca) or the low Ca (LCa) diet (0.01 wt/wt
%). *P  0.05 versus WT mice on the same diet; #P  0.069 versus WT on the same diet.
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in TK/ and WT mice. These significant interstrain differ-
ences in the response to LCa diet may have consequences for
the ability to maintain normal plasma Ca concentration in the
face of impaired renal calcium reabsorption.
Nevertheless, irrespective of the strain, hypercalciuria per-
sists on an LCa diet in TK/ mice. As the filtered load of Ca
is identical in WT and TK/ mice in the C57Bl/6 strain and
even lower in TK/ than in WT mice in the 129Sv strain,
these data demonstrate that TK/ mice have a default in
RTCa absorption. On the NCa diet, an excessive Ca absorption
from the gut may contribute to the hypercalciuria in the
TK/ mice because bone resorption does not seem to be
increased, as compared with WT mice, as attested by DPyr
measurements. In the male TK/ mice, 1,25-dihydroxyvita-
min D concentration is higher than in male WT mice. This
difference in 1,25-dihydroxyvitamin D concentration is likely
an adaptive consequence of the renal leak of Ca, allowing a
higher intestinal Ca absorption to occur to match the renal loss.
In the female TK/ mice, we did not observed a significant
increase in 1,25-dihydroxyvitamin D concentration in the
TK/ mice, but a trend toward higher values was noted.
Presently, we do not have an explanation for this difference
between genders.
A decrease in RTCa reabsorption can be induced by several
physiologic situations, such as volemic expansion or metabolic
Table 2. Phenotypic characterization of female C57Bl6/J TK/ and WT littermates on NCa diet (0.9% wt/wt
Ca) or on LCa diet (0.01% wt/wt Ca)a
0.9% wt/wt Ca 0.01% wt/wt Ca
WT (n  26) TK/ (n  23) WT (n  10) TK/ (n  9)
Weight (g) 21.9 0.4 22.1 0.4 20.3 0.4 21.9 0.5b
Food intake (g/24 h) 3.77 0.22 4.11 0.12 3.48 0.15 4.33 0.30b
Urine values
volume (ml/24 h) 1.04 0.09 1.52 0.26 0.82 0.15 1.20 0.28
creatinine excretion (mol/24 h) 2.89 0.19 3.39 0.29 2.87 0.37 3.24 0.34
Ca excretion (mol/24 h) 1.36 0.17 2.16 0.35b 0.75 0.15 1.41 0.25b
UCa/UCr (mmol/mmol) 0.46 0.04 0.61 0.08c 0.24 0.03 0.49 0.1b
Na excretion (mol/24 h) 231 14 275 22 230  33 252 34
UNa/UCr (mmol/mmol) 84.2 4.4 83.5 4.7 78.9 3.4 77.2 5.1
UCa/UNa (mol/mmol) 6.2 0.9 8.1 1.1 3.1  0.3 6.6 1.4b
UPi/UCr (mmol/mmol) 61.7 3.5 66.7 5.9 80.6 4.9 82.9 7.0
UcAMP/UCr (mol/mmol) 5.13 0.43 5.40 0.28 6.21 0.36d 7.28  0.74d
UDPyr/UCr (nmol/mmol) 14.87 1.09 14.94 0.59 19.18 0.80d 19.62  1.28d
Plasma values
total Ca (mM) 1.94 0.04 1.90 0.07 1.98 0.07 1.98 0.04
1,25-dihydroxy vitamin D (pmol/L) 210 27 262 38 563 65 517 68
protein (g/L) 37.0 0.6 35.6 0.6 36.1 0.5 35.8 0.6
creatinine (M) 14.4 1.2 15.5 1.5 9.9 0.9 11.8 1.7
PTH (pg/ml) 26.0 7.4 13.8 1.4 35.6 1.4 31.2 11.7
Pi (mM) 3.29 0.28 3.29 0.11 3.44 0.12 3.02 0.13b
aPi, inorganic phosphate.
bP  0.05 versus WT.
cP  0.069 versus WT.
dP  0.01 versus NCa diet.
Table 3. Phenotypic characterization of male C57Bl6/J
TK/ and WT littermates on NCa diet (0.9% wt/wt Ca)
0.9% wt/wt Ca
WT
(n  15)
TK/
(n  14)
Weight (g) 24.9 0.4 24.0 0.5
Food intake (g/24 h) 4.16 0.15 4.18 0.25
Urine values
volume (ml/24 h) 1.27 0.17 1.71 0.28
creatinine excretion (mol/24 h) 4.08 0.18 4.60 0.29
Ca excretion (mol/24 h) 1.56 0.16 2.54 0.44a
UCa/UCr (mmol/mmol) 0.38 0.03 0.52 0.08
Na excretion (mol/24 h) 322 19 311 26
UNa/UCr (mmol/mmol) 78.9 2.7 67.3 3.2a
UCa/UNa (mol/mmol) 5.0 0.4 8.7 1.5a
UPi/UCr (mmol/mmol) 49.9 2.3 44.1 2.3
UcAMP/UCr (mol/mmol) 7.18 0.35 6.78 0.45
UDPyr/UCr (nmol/mmol) 13.41 1.03 11.63 0.58
Plasma values
total Ca (mM) 2.20 0.08 2.03 0.1
protein (g/L) 36.7 0.6 36.2 0.7
creatinine (M) 16.6 1.4 13.5 1.3
1,25-dihydroxy vitamin D (pmol/L) 120 12 203 25b
PTH (pg/ml) 15.1 1.4 18.3 6.1
Pi (mM) 3.06 0.18 2.99 0.08
aP  0.05 versus WT.
bP  0.01 versus WT.
J Am Soc Nephrol 16: 3602–3610, 2005 Tissue Kallikrein and Tubular Ca Transport 3607
acidosis (28). Moreover, the UCa:UNa ratio was higher in
TK/ than in WT mice, suggesting that the defect in renal
tubular Ca absorption occurs independent of any change in
tubular Na transport. Similarly, under baseline conditions,
TK/ mice have similar plasma PTH concentration as WT
mice and display similar tubular responsiveness to PTH, as
shown by their urinary cAMP excretion levels. Finally, the
lower tubular Ca reabsorption in the TK/mice could not be
ascribed to higher plasma Ca or Mg concentration. In addition,
in independent experiments, plasma total CO2 concentration
was measured in both C57Bl/6 WT and TK/ mice and
found to be the same, ruling out the possibility that TK/
mice could have metabolic acidosis (unpublished results).
Therefore, in the absence of any known cause of reduced renal
tubular Ca reabsorption, the defect in tubular Ca transport is
probably related to the loss of a direct TK effect on this trans-
port. This hypothesis that TK may play a physiologic role in the
control of intrarenal Ca transport is strengthened by the fact
that the renal expression of the TK gene markedly increases
under LCa diet. However, the mechanism of this increased
expression remains unknown.
Whereas the kallikrein-deficient mice exhibited hypercalci-
uria and displayed impaired adaptation to a LCa diet, no such
abnormalities were observed in the B2/ mice. The B2 re-
ceptor is usually considered to be the only kinin receptor con-
stitutively synthesized in organs, including the kidney (29).
However in B2/ mice, the B1 receptor is induced and can
take over functions that are normally performed by the B2
receptor, such as vasodilation and cardioprotection, and that
can be suppressed in these mice by treatment with a B1 antag-
onist (30). The B2/ mice therefore were treated with a B1
antagonist, but this combined genetic and pharmacologic
blockade of kinin action at its two receptors did not affect renal
Ca excretion. Taken together, these data suggest that the effect
of kallikrein on Ca excretion is independent of kinin produc-
tion.
The data available do not allow us to determine with cer-
tainty which tubular segment contains the defect in Ca trans-
port in TK/. However, because hypercalciuria occurs in the
absence of any difference in Na intake or, presumably, in ECF
volume, the involvement of the proximal tubule is unlikely.
Similarly, a defect in Ca transport located in the thick ascending
limb of Henle would be expected to be associated with a defect
in Mg reabsorption. Because renal tubular magnesium han-
Table 4. Phenotypic characterization of C57Bl/6 B2/ and WT littermates and B2/ mice that were treated
with a B1 receptor antagonist on NCa diet (0.9% wt/wt Ca)
0.9% wt/wt Ca
WT (n  10) B2/ (n  10) B2/ (n  12)
Treatment Vehicle Vehicle B1 antagonist SSR240612
Weight (g) 22.1 0.5 20.9 0.6 23.0 0.5
Food (g/24 h) 2.99 0.23 3.44 0.31 3.73 0.25
Urine values
volume (ml/24 h) 0.94 0.17 0.90 0.18 1.26 0.13
creatinine excretion (mol/24 h) 2.68 0.27 2.51 0.27 3.20 0.24
Ca excretion (mol/24 h) 1.46 0.39 1.48 0.37 1.75 0.35
UCa/UCr (mmol/mmol) 0.50 0.08 0.53 0.11 0.53 0.08
UNa/UCr (mmol/mmol) 72.0 8.9 86.8 8.7 92.8 5.3
UCa/UNa (mol/mmol) 7.21 0.93 6.63 0.80 7.12 0.50
Plasma values
total plasma Ca (mM) 1.82 0.04 1.78 0.05 1.86 0.04
1,25-dihydroxyvitamin D (pmol/L) 217 33 265 41 281 31
Figure 3. Effect of a LCa diet on TK gene expression in the
kidney. (A) Representative Northern blot using a TK probe on
whole-kidney mRNA of TK/ and WT mice that were sub-
jected to NCa or LCa diet. (B) Summary (mean  SEM) of
sample analysis for TK gene expression in WT and TK/
mice on a NCa and a LCa diet (n  14 per group). For each
sample, kallikrein and glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) mRNA abundance was quantified by densi-
tometric analysis. The ratio (Kallikrein mRNA/GAPDH
mRNA) was calculated. **P  0.01 versus NCa diet.
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dling seems to be similar in TK/ and WT mice, we suggest
that the renal tubular Ca transport in TK / mice is per-
turbed in the DCT and CNT, which are also sites of TK syn-
thesis.
The molecular events that link kallikrein to renal Ca metab-
olism are unknown at the present time. We did not observe any
change in the expression of TRPV5, TRPV6, NCX1, PMCA1b,
Calbindin-D9k, or Calbindin-D28k genes in TK/ mice. How-
ever, as kallikrein is synthesized in the same tubule segment as
these Ca transporters, a direct impact on a Ca transporter can
be postulated. However, this effect does not seem to be medi-
ated by kinins, despite the presence of kininogen in the distal
nephron (31). A proteolytic effect on TRPV5 or some other
unknown protein involved in TRPV5 regulation can be sug-
gested but remains to be confirmed. Regulation of ion transport
by limited proteolysis of transporters, involving serine pro-
teases other than kallikrein, has been documented for Na reab-
sorption and epithelial Na channel (32). This hypothesis would
be consistent with the well-documented observation that TK
has broad enzymatic specificity in vitro and can hydrolyze
several protein substrates besides kininogen (33–35). This study
in the mouse suggests that TK is a physiologic regulator of the
renal tubular Ca reabsorption from the renal tubule.
A loss-of-function polymorphism of the kallikrein gene was
described in humans (36) with a marked reduction in kallikrein
activity as a consequence of an amino acid mutation (R53H). It
will be interesting to find out whether this polymorphism is
associated with any defect in renal Ca handling in humans.
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